OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.430
+0.015 (1.06%)
At close: Oct 15, 2026, 4:00 PM EDT
1.410
-0.020 (-1.40%)
After-hours: Oct 15, 2026, 4:48 PM EDT
OKYO Pharma Employees
OKYO Pharma had 5 employees as of March 31, 2026. The number of employees increased by 1 or 25.00% compared to the previous year. That makes OKYO Pharma the 41,777th largest employer in the world and 6,521st in the United States.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,789,931
Market Cap
75.05M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 5 | 1 | 25.00% |
| Mar 31, 2025 | 4 | 1 | 33.33% |
| Mar 31, 2024 | 3 | -5 | -62.50% |
| Mar 31, 2023 | 8 | 1 | 14.29% |
| Mar 31, 2022 | 7 | 1 | 16.67% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| Pelthos Therapeutics | 92 |
| MindWalk Holdings | 77 |
| Acrivon Therapeutics | 76 |
| Cardiff Oncology | 31 |
| Cognition Therapeutics | 14 |
| Nutriband | 13 |
| MAIA Biotechnology | 13 |
OKYO News
- 9 days ago - Okyo Pharma announces first patients enrolled in NEPTUNE trial - TheFly
- 9 days ago - OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain - GlobeNewsWire
- 16 days ago - OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences - GlobeNewsWire
- 5 weeks ago - OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026 - GlobeNewsWire
- 5 weeks ago - OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Okyo Pharma management to meet virtually with Piper Sandler - TheFly
- 2 months ago - Okyo Pharma CSO Raj Patil purchases 3,363 shares at $1.49 - TheFly
- 2 months ago - OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer - GlobeNewsWire